Andi Camden, Hilary K Brown, Roxana Dragan, Tara Gomes, Jennifer A Hutcheon, Lauren Kelly, Hong Lu, Amy Metcalfe, Nazeem Muhajarine, Nathan Nickel
{"title":"Perinatal Opioid Use: Improving Insights through Federated Analysis of Linked Administrative Data.","authors":"Andi Camden, Hilary K Brown, Roxana Dragan, Tara Gomes, Jennifer A Hutcheon, Lauren Kelly, Hong Lu, Amy Metcalfe, Nazeem Muhajarine, Nathan Nickel","doi":"10.23889/ijpds.v11i5.3535","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Linked administrative data from 5 Canadian provinces were harmonized for the Canadian Perinatal Opioid Project, a nationally funded project. Using these data, we estimated opioid prescribing patterns during/after pregnancy at the national level and conducted cross-provincial comparisons.</p><p><strong>Approach: </strong>This population-based cohort study used linked administrative health records from Alberta, British Columbia, Manitoba, Ontario, and Saskatchewan. Included were all pregnancies to individuals aged 12-50 years, 2013-2023. Opioid use and prescribing patterns (type, duration, dose, timing) were measured from conception through to 1-year after the end of pregnancy. We conducted federated and province-specific analyses to produce pan-Canadian estimates of perinatal opioid use. Poisson models analyzed trends in perinatal opioid use and generated adjusted relative risks (aRR) of perinatal opioid use by socio-demographic and clinical factors. This research is being conducted in collaboration with people with lived/living experience.</p><p><strong>Results: </strong>Data from Alberta Health Services/Alberta Health, PopDataBC, Manitoba Centre for Health Policy, ICES, and Health Research Data Platform-Saskatchewan were harmonized. Federated data analyses are underway and will be completed by May 2026. We anticipate 3.2 million pregnancies (325,000 pregnancies/year). Preliminary analyses from Ontario show the prevalence of prenatal opioid exposure is 4.1% based on 1.6 million pregnancies.</p><p><strong>Conclusions/implications: </strong>Improving health system data access through multi-regional research using harmonized administrative data addresses important knowledge gaps and will generate the first pan-Canadian estimates of perinatal opioid use. This information is needed to inform prevention efforts, harm reduction, and tailored interventions for people who use opioids during/after pregnancy.</p>","PeriodicalId":36483,"journal":{"name":"International Journal of Population Data Science","volume":"11 5","pages":"3535"},"PeriodicalIF":2.2000,"publicationDate":"2026-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13426528/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Population Data Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23889/ijpds.v11i5.3535","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Linked administrative data from 5 Canadian provinces were harmonized for the Canadian Perinatal Opioid Project, a nationally funded project. Using these data, we estimated opioid prescribing patterns during/after pregnancy at the national level and conducted cross-provincial comparisons.
Approach: This population-based cohort study used linked administrative health records from Alberta, British Columbia, Manitoba, Ontario, and Saskatchewan. Included were all pregnancies to individuals aged 12-50 years, 2013-2023. Opioid use and prescribing patterns (type, duration, dose, timing) were measured from conception through to 1-year after the end of pregnancy. We conducted federated and province-specific analyses to produce pan-Canadian estimates of perinatal opioid use. Poisson models analyzed trends in perinatal opioid use and generated adjusted relative risks (aRR) of perinatal opioid use by socio-demographic and clinical factors. This research is being conducted in collaboration with people with lived/living experience.
Results: Data from Alberta Health Services/Alberta Health, PopDataBC, Manitoba Centre for Health Policy, ICES, and Health Research Data Platform-Saskatchewan were harmonized. Federated data analyses are underway and will be completed by May 2026. We anticipate 3.2 million pregnancies (325,000 pregnancies/year). Preliminary analyses from Ontario show the prevalence of prenatal opioid exposure is 4.1% based on 1.6 million pregnancies.
Conclusions/implications: Improving health system data access through multi-regional research using harmonized administrative data addresses important knowledge gaps and will generate the first pan-Canadian estimates of perinatal opioid use. This information is needed to inform prevention efforts, harm reduction, and tailored interventions for people who use opioids during/after pregnancy.